PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITORS - BIOCHEMICAL ASPECTS

被引:59
作者
RIJKEN, DC
机构
来源
BAILLIERES CLINICAL HAEMATOLOGY | 1995年 / 8卷 / 02期
关键词
D O I
10.1016/S0950-3536(05)80269-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although this chapter does not represent a historical review, it will be clear how the biochemistry of t-PA, u-PA, PAI-1 and PAI-2 has evolved and where we stand in 1994. While the functional activities of the proteins were recognized at least three to four decades ago, highly purified preparations became available around 1980. In the mid-eighties the cDNAs of the proteins were cloned, representing a major breakthrough in the biochemistry of the four proteins. Amino acid sequences were derived from the nucleotide sequences, homologies with other proteins were recognized and larger amounts of (recombinant) proteins became available for research. In addition, mutant proteins were prepared by recombinant DNA technology, enabling investigation of structure-function relationships. This report is mainly based on the latter studies. Detailed information about three-dimensional structures of the proteins and the mode of interaction with other macromolecules is still lacking. To obtain this information will be the goal for biochemists in the coming years. © 1995 Baillière Tindall. All rights reserved.
引用
收藏
页码:291 / 312
页数:22
相关论文
共 128 条
[1]  
Abercrombie, Buchinski, Salvato, Et al., Fibrin specific thrombolysis by two-chain urokinase-type plasminogen activator cleaved after Arginine 156 by thrombin, Thrombosis and Haemostasis, 64, pp. 426-432, (1990)
[2]  
Adams, Griffin, Nachajko, Et al., A synthetic DNA encoding a modified human urokinase resistant to inhibition by serum plasminogen activator inhibitor, The Journal of Biological Chemistry, 266, pp. 8476-8482, (1991)
[3]  
Bakker, van der Greef, Rehberg, Et al., Introduction of lysine and clot binding properties in the kringle one domain of tissue-type plasminogen activator, The Journal of Biological Chemistry, 268, pp. 18496-18501, (1993)
[4]  
Barlati, Paracini, Bellotti, DePetro, Tyrosine phosphorylation of human urokinase-type plasminogen activator, FEBS Letters, 281, pp. 137-140, (1991)
[5]  
Beebe, Miles, Plow, A linear amino acid sequence involved in the interaction of t-PA with its endothelial cell receptor, Blood, 74, pp. 2034-2037, (1989)
[6]  
Delin, Biology and facultative secretion of plasminogen activator inhibitor-2, Thrombosis and Haemostasis, 70, pp. 144-147, (1993)
[7]  
Bennett, Paoni, Keyt, Et al., High resolution analysis of functional determinants on human tissue-type plasminogen activator, The Journal of Biological Chemistry, 266, pp. 5191-5201, (1991)
[8]  
Bergum, Gardell, Vampire bat salivary plasminogen activator exhibits a strict and fastidious requirement for polymeric fibrin as its cofactor, unlike human tissue-type plasminogen activator. A kinetic analysis, The Journal of Biological Chemistry, 267, pp. 17726-17731, (1992)
[9]  
Binnema, Van Iersel, Dooijewaard, Quantitation of urokinase antigen in plasma and culture media by use of an ELISA, Thrombosis Research, 43, pp. 569-577, (1986)
[10]  
Binnema, Dooijewaard, Van Iersel, Et al., The contact-system dependent plasminogen activator from human plasma: identification and characterization, Thrombosis and Haemostasis, 64, pp. 390-397, (1990)